The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Emblaveo
aztreonam and avibactam · AZTREONAM 127 mg/mL; AVIBACTAM 42.3 mg/mL · Powder, For Solution · Intravenous · AbbVie Inc.
NDC 00074-3878-10 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 12 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$1.77per billing unit (10 MG)HCPCS J0458 · Jul 1, 2026
- Federal ceiling (Big4)$243.72per unitAbbvie US LLC · Dec 1, 2025
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$3,270.00
Reported to Texas DSHS · 2026 annual filing · Abbvie Inc
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 10 MG
$1.773
HCPCS J0458 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA217906
- TE code
- —
- Approval date
- Feb 7, 2025
- Patents / exclusivity
- 7 patents, 2 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | GAIN | Feb 7, 2033 |
| exclusivity | NP | Feb 7, 2028 |
| patent | 9695122 | Jun 15, 2032 |
| patent | 8969566 | Jun 15, 2032 |
| patent | 9284314 | Jun 15, 2032 |
| patent | 8471025 | Aug 12, 2031 |
| patent | 8835455 | Oct 8, 2030 |
| patent | 7612087 | Nov 12, 2026 |
| patent | 7112592 | Jan 7, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of aztreonam and avibactam (Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AbbVie Inc. | AZTREONAM 127 mg/mL; AVIBACTAM 42.3 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| AbbVie Inc. | AZTREONAM 42.3 mg/mL; AVIBACTAM 127 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| AbbVie Inc. | AVIBACTAM 42.3 mg/mL; AZTREONAM 127 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Emblaveo — NDC 00074-3878-10," retrieved September 3, 2026, https://drugdashboards.com/drug/00074387810.
Free to cite with attribution — see how the data is put together.